Back

Clinical impact and genomic profile in patients with nonsyndromic FBN1-related thoracic aortic aneurysm and dissection

29 August 2026 (16:21 - 16:33)
Organised by: Logo
Congress Presentation Part of: Aortic diseases: from genomics to general application Aortic Aneurysm, Thoracic ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Hiroki Yagi

The University of Tokyo Hospital, Tokyo (Japan)

4 More presentations in this session

Presentation thumbnail
[18F]-FAPI PET/CT delineates FAP expression dynamics and distribution in acute aortic syndrome: clinical prognosis and intervention implications
Doctor S. Wang (Beijing, CN)
Abstract Slides
Presentation thumbnail
Flow displacement and increased circumferential wall shear stress predict ascending aortic dilatation: a prospective 5-year follow-up study
Doctor S. Sillanmaki (Kuopio, FI)
Abstract Slides
Presentation thumbnail
Integrative genomics identifies putative causal genes and therapeutic targets in thoracic aortic disease
Ms J. Horjus (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Associations between antidiabetic drug classes and aortic aneurysm risk in patients with type 2 diabetes: a nationwide cohort study
Doctor Y. Lu (Taichung, TW)
Abstract Slides

Access the full session

Session thumbnail
Aortic diseases: from genomics to general application
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 16:21 CET
You may be interested in
thumbnail
Congress Presentation
Utility of familial screening in non-syndromic thoracic aortic disease
27 August 2021
thumbnail
Congress Presentation
Exploration of cyclophilin A antibody anti-eCypA as a new approach in the treatment of marfan syndrome
31 August 2025
thumbnail
Congress Presentation
Loss of function in cytoskeletal genes associates with early onset atrial fibrillation
1 September 2019
thumbnail
Congress Presentation
Exploring the proteomic landscape of spontaneous coronary artery dissection - insight into pathophysiology and potential biomarker candidates
21 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources